Navigation Links
Adalimumab is a promising therapy for children with Crohn's disease
Date:8/6/2012

Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

Steroids are commonly used in Crohn's disease, but can stunt growth and delay puberty. Incidence of this disease, which causes intestinal inflammation, is on the rise in children.

This study is the largest double-blind study of an anti-TNF agent in children with Crohn's disease. It found that more than 80 percent of children with moderate to severe Crohn's disease responded to adalimumab within a month (response was defined as a decrease in Pediatric Crohn's Disease Activity Index ≥ 15 points from baseline). By six months, approximately 34 percent of patients were in clinical remission, and after a year, 28.4 percent were in remission.

The promising results of treatment with adalimumab are extremely encouraging, especially in this clinically challenging population resistant to conventional therapy. The goal of treatment is not only to induce and maintain clinical remission, but also to restore and preserve normal growth and pubertal development in these children.

Researchers studied 192 patients, ages 6 to 17 years, across 45 sites in Canada, Europe and the U.S. between April 2007 and May 2010. Depending on their body weight, patients were assigned to either a high-dose group, which received 40 mg of adalimumab every other week or 20 mg of adalimumab every other week. Patients assigned to a low-dose group either received 20 mg of adalimumab every other week or 10 mg of adalimumab every other week, again depending on their body weight. More children that received high than low dose were in remission at week 26, but the difference between dose groups was not statistically significant.


'/>"/>

Contact: Alissa J. Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Page: 1

Related medicine news :

1. Head-to-head study in RA shows that abatacept has comparable efficacy to adalimumab
2. New study identifies promising, achievable solutions to Nigerias childhood mortality crisis
3. Screening for breast cancer without X-rays: Lasers and sound merge in promising diagnostic technique
4. Stem Cell Study Shows Promising Results Against Heart Failure
5. Researchers make promising discovery in pursuit of effective lymphoma treatments
6. Diabetes drug could be a promising therapy for traumatic brain injury
7. Leukemia inhibitory factor may be a promising target against pancreatic cancer
8. Zebrafish reveal promising mechanism for healing spinal cord injury
9. Research identifies a promising new therapeutic target for aggressive breast cancer
10. Spice ingredient in curry emerges as promising basis for an Alzheimers disease medicine
11. KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... new pain relief targets that could be used ... at King,s College London made the discovery when ... periphery of the body. , Dr Marzia Malcangio ... underlying pain generation and our findings could help ... , One potential side effect of some chemotherapy ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
(Date:4/17/2014)... from Boston University School of Medicine (BUSM) have ... consumption in an experimental model. The findings, reported ... Alcohol Abuse , may lead to more effective ... is one of the leading causes of illness ... negative economic impact by limiting the productivity of ...
(Date:4/17/2014)... 2014) Population Council scientists and their partners have found ... can prevent the transmission of multiple sexually transmitted infections ... HIV, herpes simplex virus 2 (HSV-2), and human papillomavirus ... that the gel is effective against multiple strains of ... vagina against all three viruses of at least eight ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... are inadequate in countries with high rates of multi-drug ... MDR-TB, patients are nearly twice as likely to fail ... rates, according to a new analysis of World Health ... TB treatment regimens need to updated and revised to ...
... completion of health risk assessment resulted in a 65% employee completion rate; ... ... 1, 2008 -- Employers are increasingly using incentives as the carrot to ... brief from HealthFitness (OTC BB: HFIT) zeros in on the use of ...
... Nearly six million people in the UK have had self-inflicted DIY disasters. ... home insurance as a result. , ... Cardiff, UK (PRWEB) August 1, ... disasters, according to Confused.com - the UK,s leading insurance price comparison site., ...
... in the document scanning industry, announced that its ... http://www.imagedocusa.com . The site introduces a ... businesses to "Go Paperless!" ImageDoc USA, headquartered ... and has created a reputation as a niche ...
... World Vision calls for action to protect, care for children impacted by ... HIV and AIDS, ... ... Aug. 1 A leading humanitarian agency has,today warned that the world,s biggest conference on ...
... shows that cannabinoid cell surface receptor CB1 plays a ... the Aug. 1 edition of the journal Cancer ... and nausea, elevating mood and stimulating appetite by serving ... signaling molecules. It now may serve as a new ...
Cached Medicine News:Health News:Strategies to control TB outdated, inadequate 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 3Health News:DIY Disasters Cost the Average Brit 669.58, Says Confused.com* 2Health News:DIY Disasters Cost the Average Brit 669.58, Says Confused.com* 3Health News:ImageDoc USA, Inc. Launches "Go Paperless!" Website 2Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 2Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 3Health News:Turned-off cannabinoid receptor turns on colorectal tumor growth 2Health News:Turned-off cannabinoid receptor turns on colorectal tumor growth 3
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that it expects revenues for the fourth quarter ... full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... -- Acumed,s new SLIC Screw System - a jointed ... place and insert the screw accurately - offers surgeons ... repair or reconstruction as it holds the bones reduced ... http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC Screw is ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... Pharma market research thought leaders are discovering new ways ... the pharmaceutical industry. The last twelve months has shown ... market research is no exception. But those who are ... will certainly rise to be the new leaders of tomorrow. ...
... Nov. 11 VIVUS, Inc. (Nasdaq: VVUS ) today announced ... the company at the Lazard Capital Markets 6th Annual Healthcare Conference. ... in New York, NY on Wednesday, November 18, 2009 at 1:45 ... presentation will be available at http://ir.vivus.com . , ...
Cached Medicine Technology:Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 2VIVUS to Present at Lazard Capital Markets Healthcare Conference 2
... three preferred cardiac markers are ... immunoassay system. Cardiac Troponin I ... very high sensitivity and specificity ... appears very soon following AMI. ...
IRMA kit for detection of the cardiac marker Myoglobin...
... For the quantitative determination of myoglobin ... Myoglobin ELISA test is based on the ... assay. The assay system utilizes a unique ... determinant on the myoglobin molecule. Mouse monoclonal ...
... Prolactin ELISA kit is used for the ... or plasma. Human prolactin (lactogenic hormone) is ... molecular weight of approximately 23,000 daltons. The ... phase direct sandwich ELISA method. The samples ...
Medicine Products: